Last updated: Oct 30, 2026, 12:00 AM

Replimune Group Inc Exchange (NASDAQ, USD)

REPL

13.05
+0.58 (+4.65%)
HealthcareBiotechnology
Invest Today
Invest Today
1 year return (CAGR)
48.30%
3 year return (CAGR)
-4.19%
5 year return (CAGR)
-15.19%
10 year return (CAGR)
-
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
1.23B
Price/Sales
-
Ent value
1.19B
Price/Book
11.64
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
-
PEG
-
Forward P/E
-
EPS growth
14.11%

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

Loading...
Stock price data
Open12.45
Daily high13.16
Daily low12.21
Daily Volume4.30M
All-time high52.65
1y analyst estimate19.50
Beta0.94
EPS (TTM)-3.07
Dividend per share0.00
Ex-div date-
Next earnings date-

Ready to capitalize on Replimune Group Inc's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
REPLS&P500
Current price drop from All-time high-75.21%-1.21%
Highest price drop-96.77%-56.47%
Date of highest drop13 Apr 20269 Mar 2009
Avg drop from high-56.54%-10.65%
Avg time to new high61 days12 days
Max time to new high1483 days1805 days